The Prague Post - DR Congo drug manufacturing plan sparks safety concerns

EUR -
AED 4.15647
AFN 80.353882
ALL 98.652984
AMD 441.260635
ANG 2.039528
AOA 1037.705819
ARS 1328.82124
AUD 1.757588
AWG 2.036936
AZN 1.926581
BAM 1.957844
BBD 2.290291
BDT 137.813865
BGN 1.957844
BHD 0.427646
BIF 3374.022162
BMD 1.131631
BND 1.471836
BOB 7.838182
BRL 6.416799
BSD 1.134284
BTN 95.862071
BWP 15.444122
BYN 3.712175
BYR 22179.97381
BZD 2.278479
CAD 1.564882
CDF 3248.91331
CHF 0.933106
CLF 0.027968
CLP 1073.273408
CNY 8.228769
CNH 8.159
COP 4830.538021
CRC 573.598783
CUC 1.131631
CUP 29.98823
CVE 110.380227
CZK 24.938857
DJF 201.990859
DKK 7.462837
DOP 66.619545
DZD 149.835414
EGP 57.354806
ERN 16.97447
ETB 151.786651
FJD 2.552847
FKP 0.852666
GBP 0.853063
GEL 3.100481
GGP 0.852666
GHS 15.936636
GIP 0.852666
GMD 80.913298
GNF 9825.256645
GTQ 8.73612
GYD 238.008458
HKD 8.770742
HNL 29.457751
HRK 7.53044
HTG 148.044545
HUF 404.399583
IDR 18634.572894
ILS 4.059957
IMP 0.852666
INR 95.652832
IQD 1485.951194
IRR 47655.827295
ISK 146.104689
JEP 0.852666
JMD 179.917817
JOD 0.802554
JPY 163.764009
KES 146.72694
KGS 98.961581
KHR 4544.744286
KMF 491.693774
KPW 1018.468172
KRW 1584.169006
KWD 0.347004
KYD 0.945287
KZT 586.001731
LAK 24528.605561
LBP 101634.096452
LKR 339.664578
LRD 226.866828
LSL 20.880697
LTL 3.341413
LVL 0.684512
LYD 6.193465
MAD 10.51788
MDL 19.510367
MGA 5151.377554
MKD 61.594299
MMK 2375.987505
MNT 4043.462656
MOP 9.056154
MRU 45.180164
MUR 51.296696
MVR 17.438538
MWK 1966.85321
MXN 22.204145
MYR 4.806604
MZN 72.424561
NAD 20.880697
NGN 1818.384184
NIO 41.743576
NOK 11.7981
NPR 153.379113
NZD 1.903324
OMR 0.435405
PAB 1.134284
PEN 4.158641
PGK 4.702909
PHP 62.961694
PKR 318.740835
PLN 4.280786
PYG 9075.473943
QAR 4.139321
RON 4.978048
RSD 117.322474
RUB 93.750523
RWF 1600.971264
SAR 4.243851
SBD 9.43829
SCR 16.078785
SDG 679.548434
SEK 10.919168
SGD 1.468048
SHP 0.889285
SLE 25.789781
SLL 23729.724523
SOS 648.27674
SRD 41.672341
STD 23422.483504
SVC 9.925361
SYP 14713.260469
SZL 20.871788
THB 37.445578
TJS 11.740056
TMT 3.96071
TND 3.403052
TOP 2.650396
TRY 43.669743
TTD 7.69203
TWD 34.762919
TZS 3054.689385
UAH 47.359639
UGX 4155.337782
USD 1.131631
UYU 47.59969
UZS 14632.274721
VES 98.155404
VND 29428.072394
VUV 137.031667
WST 3.144268
XAF 656.642473
XAG 0.035318
XAU 0.000349
XCD 3.05829
XDR 0.816653
XOF 656.642473
XPF 119.331742
YER 276.853804
ZAR 20.846577
ZMK 10186.040293
ZMW 31.482865
ZWL 364.384822
  • CMSD

    0.0600

    22.32

    +0.27%

  • RBGPF

    67.2100

    67.21

    +100%

  • BCC

    3.4400

    96.15

    +3.58%

  • SCS

    0.2700

    10.14

    +2.66%

  • RYCEF

    0.1300

    10.35

    +1.26%

  • RIO

    1.1500

    59.7

    +1.93%

  • RELX

    0.9400

    55.02

    +1.71%

  • GSK

    0.3200

    39.07

    +0.82%

  • NGG

    0.0300

    71.68

    +0.04%

  • CMSC

    0.0700

    22.1

    +0.32%

  • JRI

    0.0600

    13.07

    +0.46%

  • BCE

    0.0100

    21.45

    +0.05%

  • VOD

    -0.1200

    9.61

    -1.25%

  • BTI

    -0.1300

    43.17

    -0.3%

  • BP

    0.2400

    28.12

    +0.85%

  • AZN

    1.9300

    72.44

    +2.66%

DR Congo drug manufacturing plan sparks safety concerns
DR Congo drug manufacturing plan sparks safety concerns / Photo: Barbara DEBOUT - AFP

DR Congo drug manufacturing plan sparks safety concerns

Sitting at his desk overlooking a pharmaceutical factory floor on the outskirts of the Congolese capital Kinshasa, Joss Ilunga Dijimba, 52, cracked a jovial smile.

Text size:

"It's not easy doing business in Congo," he said.

His family was forced to relocate the factory in the 1990s to survive bouts of mass looting. And nowadays, there are onerous taxes, customs duties, and problems retaining talented staff.

His company, which employs about 40 people and produces generics such as paracetamol, is one of a tiny number of drug manufacturers in the Democratic Republic of Congo, an impoverished nation roughly the size of Western Europe.

But a government plan to require hospitals and NGOs to buy more locally produced drugs could soon boost the fledgling pharmaceutical industry -- despite fears in some quarters that safety standards are far below international norms.

Several NGOs, some of which provide medical care in the DRC's conflict-torn east, have requested opt-outs.

At the small Pharmagros plant, behind barbed-wire walls near the Congo river, men in hairnets and white coats formulate medicines with imported precursor using lab equipment in airconditioned rooms.

"Promoting local industry's a good thing," said Dijimba, a University of Texas graduate, insisting that several Congolese firms, including his, maintained high standards.

"It could grow the middle class."

About 73 percent of the DRC's population of 90 million lives on under $1.9 a day, according to the World Bank. Most products in the African country are imported.

- 'At your own peril' -

The Congolese government has designated 35 drug molecules, including paracetamol, that medical facilities will be required to purchase in locally made form.

The government wants to stimulate business without banning imports, said Donatien Kabamb Kabey, the pharmaceuticals director at the DRC's health ministry.

He explained that all the molecules can be replaced with imported equivalents, suggesting that ibuprofen could replace paracetamol, for example.

Although not yet implemented, the policy already appears to be working.

Fifteen new pharma businesses are setting up in the DRC ahead of the new rules, Kabey said, which will add to the existing 24.

The policy was partly designed to encourage factories to return after fleeing the country in the 1990s, he added, when unpaid soldiers went on the rampage towards the end of ex-dictator Mobutu Sese Seko's reign.

But experts warn that Congolese-made medicines face a major challenge: reassuring doctors and patients that they meet regulatory standards.

"When you go to the private sector in Congo, you do it at your own peril," said Ed Vreeke, who runs the Belgium-based independent pharmaceutical auditing firm Quamed.

"They know darn well that the quality they produce is not good."

Vreeke said Congolese regulators had improved, but the country lacked the massive resources needed to properly perform audits, check labels, and inspect the chemical composition of drugs for safety.

Kabey, whose department at the health ministry oversees inspections, said standards had improved "enormously" in recent years, but did not provide further details.

He said the government was establishing a national quality-control lab.

- 'A huge thing' -

Shoddy or falsified medicines kill hundreds of thousands of people every year, according to the World Health Organization, mostly in poor countries.

The DRC's hot and humid climate also poses storage problems.

A 2021 study of both imported and locally produced eye drops sold in Kinshasa, for example, showed that three out of the seven products tested were substandard. The one sample manufactured in the DRC was contaminated.

Outside a pharmacy in Kinshasa's upmarket Gombe district, clutching a bag of medicines, 29-year-old corporate lawyer Joelle Mamputu said she didn't pay attention to where drugs were made but said she had "no prejudice".

However, a 52-year-old public servant named Olivier said there was "quite a difference" between Congolese and foreign drugs.

He added he would buy Congolese drugs were the quality the same.

Despite official assurances, major international NGOs such as Doctors Without Borders (MSF) and Medecins du Monde (MDM) have requested opt-outs from the purchasing requirements, several humanitarian workers said.

MSF declined to comment.

MDM confirmed it had asked for an exemption due to concerns over quality and capacity to meet demand.

"It's a huge thing," said one humanitarian who asked for anonymity, explaining that the new rules will affect all non-governmental organisations, hospitals and pharmacies.

Many aid workers understand the need to promote enterprise, he said, but there are internal disagreements about whether to compromise on quality.

"We need to have high quality standards for everyone, but the reality of the country is that sometimes it's impossible".

W.Urban--TPP